Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Weekly Docetaxel and Cisplatin for Locoregional Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT00268671 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00268671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00268671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Weekly Docetaxel and Cisplatin for Locoregional Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Lead sponsor
Sanofi
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2003
Completion date
April 30, 2006
Enrollment
45
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck neoplasms